• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Raloxifene Teva 60 mg
    / Teva Pharmaceutical Industries Ltd


    Active Ingredient
    Raloxifene 60 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30

    not in the basket chart

    Dosage

    The generally accepted dosage is One tablet once daily with or without food at the same time every day. Please refer to the license holder for further details.


    Indications

    Treatment of osteoporosis in post-menopausal women.- Prevention of osteoporosis in post-menopausal women.
    Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis.
    Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.


    Contra-Indications

    Hypersensitivity to the active substance or any of its excipients.
    Patients who are on anticoagulant therapy.
    History or present DVT, PE or Retinal vein thrombosis.
    Pregnancy, lactation.
    Patients who are immobile for a long period of time.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE